Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Sophie Petit-Zeman, Director of Patient Involvement at the Oxford Biomedical Research Centre (BRC), has praised the patient involvement in the OVIVA study (Oral versus Intravenous Antibiotics) that is run by SITU.

Oviva study praised by oxford biomedical research centre director of patient involvement

 OVIVA

 

 The OVIVA study, (Chief Investigator Dr Matthew Scarborough, Study Physician Dr Ho Kwong Li, Study Coordinator Rhea Zambellas) has been praised by Dr Sophie Petit-Zeman in her blog on the BRC website. Sophie was impressed at the engagement of the patient member of the trial steering committee, who got in touch regarding recruitment to the study. To read more about the work that the OVIVA study is doing, you can read Sophie's blog here.

 

You can find out more about the OVIVA study on it's webpage, or by contacting the study coordinator, Ms Rhea Zambellas, or the SITU Research Manager (Orthopaedics and Plastics), Mrs Cushla Cooper.

 

SITU is currently looking for patients and members of the public to join its Research User Group (RUG), as part of its patient and public involvement strategy. If you want to find out more, please click here, or email Nicola Farrar at situ@nds.ox.ac.uk.